These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 11820644)
1. The expression of oncogenes in tumour tissues of breast carcinoma patients. Rzymowska J; Grzybowska-Szatkowska L Folia Histochem Cytobiol; 2001; 39 Suppl 2():93-5. PubMed ID: 11820644 [TBL] [Abstract][Full Text] [Related]
3. Loss of Bcl-2 in invasive breast cancer is associated with high rates of cell death, but also with increased proliferative activity. van Slooten HJ; van de Vijver MJ; van de Velde CJ; van Dierendonck JH Br J Cancer; 1998 Mar; 77(5):789-96. PubMed ID: 9514059 [TBL] [Abstract][Full Text] [Related]
4. [Correlation between apoptotic index, bcl-2 protein expression and progression and prognosis in breast carcinoma]. Zhang GJ; Kimijima I; Watanabe T; Kanno M; Sagara H; Furukawa Y; Tsuchiya A; Abe R Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():415-21. PubMed ID: 9589045 [TBL] [Abstract][Full Text] [Related]
5. Neonatal diethylstilbestrol treatment alters the estrogen-regulated expression of both cell proliferation and apoptosis-related proto-oncogenes (c-jun, c-fos, c-myc, bax, bcl-2, and bcl-x) in the hamster uterus. Zheng X; Hendry WJ Cell Growth Differ; 1997 Apr; 8(4):425-34. PubMed ID: 9101088 [TBL] [Abstract][Full Text] [Related]
6. Biological indicators of aggressiveness in T1 ductal invasive breast cancer. Bucci B; Carico E; Rinaldi A; Froio F; Puce YM; D'Agnano I; Vecchione A; Brunetti E Anticancer Res; 2001; 21(4B):2949-55. PubMed ID: 11712792 [TBL] [Abstract][Full Text] [Related]
7. Low expression of bcl-2 in Brca1-associated breast cancers. Freneaux P; Stoppa-Lyonnet D; Mouret E; Kambouchner M; Nicolas A; Zafrani B; Vincent-Salomon A; Fourquet A; Magdelenat H; Sastre-Garau X Br J Cancer; 2000 Nov; 83(10):1318-22. PubMed ID: 11044356 [TBL] [Abstract][Full Text] [Related]
8. Synergistic cooperation between c-Myc and Bcl-2 in lymph node progression of T1 human breast carcinomas. Sierra A; Castellsague X; Escobedo A; Moreno A; Drudis T; Fabra A Breast Cancer Res Treat; 1999 Mar; 54(1):39-45. PubMed ID: 10369079 [TBL] [Abstract][Full Text] [Related]
9. RRR-alpha-tocopheryl succinate inhibits EL4 thymic lymphoma cell growth by inducing apoptosis and DNA synthesis arrest. Yu W; Sanders BG; Kline K Nutr Cancer; 1997; 27(1):92-101. PubMed ID: 8970189 [TBL] [Abstract][Full Text] [Related]
10. Expressions of p53, c-MYC, BCL-2 and apoptotic index in human osteosarcoma and their correlations with prognosis of patients. Wu X; Cai ZD; Lou LM; Zhu YB Cancer Epidemiol; 2012 Apr; 36(2):212-6. PubMed ID: 21890444 [TBL] [Abstract][Full Text] [Related]
11. Differential effect of anti-apoptotic genes Bcl-xL and c-FLIP on sensitivity of MCF-7 breast cancer cells to paclitaxel and docetaxel. Wang Z; Goulet R; Stanton KJ; Sadaria M; Nakshatri H Anticancer Res; 2005; 25(3c):2367-79. PubMed ID: 16080463 [TBL] [Abstract][Full Text] [Related]
12. [Relationship between expressions of telomerase genes and apoptosis related genes in mammary ductal atypical hyperplasia]. Song M; Li BL; Mi XY; Gao YX; Song JY Ai Zheng; 2002 May; 21(5):484-8. PubMed ID: 12452037 [TBL] [Abstract][Full Text] [Related]
13. Apoptosis in colorectal carcinoma occurring in patients aged 45 years and under: relationship to prognosis, mitosis, and immunohistochemical demonstration of p53, c-myc and bcl-2 protein products. Langlois NE; Lamb J; Eremin O; Heys SD J Pathol; 1997 Aug; 182(4):392-7. PubMed ID: 9306959 [TBL] [Abstract][Full Text] [Related]
14. [The expression of bcl-2, P53 and c-erbB-2 onco-proteins in breast cancer and their clinicopathological significance]. Gao L; Ding H; Deng Y Zhonghua Bing Li Xue Za Zhi; 1996 Jun; 25(3):165-8. PubMed ID: 9275673 [TBL] [Abstract][Full Text] [Related]
15. Combined histone deacetylase inhibition and tamoxifen induces apoptosis in tamoxifen-resistant breast cancer models, by reversing Bcl-2 overexpression. Raha P; Thomas S; Thurn KT; Park J; Munster PN Breast Cancer Res; 2015 Feb; 17(1):26. PubMed ID: 25848915 [TBL] [Abstract][Full Text] [Related]
16. Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Fanidi A; Harrington EA; Evan GI Nature; 1992 Oct; 359(6395):554-6. PubMed ID: 1406976 [TBL] [Abstract][Full Text] [Related]
17. Apoptosis-related gene expression in benign prostatic hyperplasia and prostate carcinoma. Iacopino F; Angelucci C; Lama G; Zelano G; La Torre G; D'Addessi A; Giovannini C; Bertaccini A; Macaluso MP; Martorana G; Sica G Anticancer Res; 2006; 26(3A):1849-54. PubMed ID: 16827116 [TBL] [Abstract][Full Text] [Related]
18. MYC Is a Major Determinant of Mitotic Cell Fate. Topham C; Tighe A; Ly P; Bennett A; Sloss O; Nelson L; Ridgway RA; Huels D; Littler S; Schandl C; Sun Y; Bechi B; Procter DJ; Sansom OJ; Cleveland DW; Taylor SS Cancer Cell; 2015 Jul; 28(1):129-40. PubMed ID: 26175417 [TBL] [Abstract][Full Text] [Related]
19. In vivo patterns of Bcl-2 family protein expression in breast carcinomas in relation to apoptosis. Rochaix P; Krajewski S; Reed JC; Bonnet F; Voigt JJ; Brousset P J Pathol; 1999 Mar; 187(4):410-5. PubMed ID: 10398099 [TBL] [Abstract][Full Text] [Related]
20. Correlation between BRCA1 expression and apoptosis-related biological parameters in sporadic breast carcinomas. Yang Q; Yoshimura G; Nakamura M; Nakamura Y; Suzuma T; Umemura T; Mori I; Sakurai T; Kakudo K Anticancer Res; 2002; 22(6B):3615-9. PubMed ID: 12552965 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]